SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006443
Filing Date
2020-05-12
Accepted
2020-05-12 17:16:13
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20200331x10q.htm 10-Q 1064685
2 EX-31.1 cycc-20200331ex31128a1ca.htm EX-31.1 19347
3 EX-31.2 cycc-20200331ex3128a597b.htm EX-31.2 19932
4 EX-32.1 cycc-20200331ex321926fb2.htm EX-32.1 6791
5 EX-32.2 cycc-20200331ex322205790.htm EX-32.2 7376
  Complete submission text file 0001558370-20-006443.txt   3930347

Data Files

Seq Description Document Type Size
6 EX-101.INS cycc-20200331.xml EX-101.INS 633930
7 EX-101.SCH cycc-20200331.xsd EX-101.SCH 31684
8 EX-101.CAL cycc-20200331_cal.xml EX-101.CAL 36565
9 EX-101.DEF cycc-20200331_def.xml EX-101.DEF 144168
10 EX-101.LAB cycc-20200331_lab.xml EX-101.LAB 281011
11 EX-101.PRE cycc-20200331_pre.xml EX-101.PRE 248115
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 20870082
SIC: 2834 Pharmaceutical Preparations